E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.

Abstract:

:The E2F1 transcription factor, which is deregulated in most human cancers by mutations in the p16-cyclin D-Rb pathway, has both oncogenic and tumor-suppressive properties. This is dramatically illustrated by the phenotype of an E2F1 transgenic mouse model that spontaneously develops tumors in the skin and other epithelial tissues but is resistant to papilloma formation when subjected to a two-stage carcinogenesis protocol. Here, this E2F1 transgenic model was used to further explore the tumor-suppressive property of E2F1. Transgenic expression of E2F1 was found to inhibit ras-driven skin carcinogenesis at the promotion stage independent of the type of promoting agent used. E2F1 transgenic epidermis displayed increased expression of p19(ARF), p53, and p21(Cip1). Inactivation of either p53 or Arf in E2F1 transgenic mice restored sensitivity to two-stage skin carcinogenesis. While Arf inactivation impaired tumor suppression and p21 induction by E2F1, it did not reduce the level of apoptosis observed in E2F1 transgenic mice. Based on these findings, we propose that E2F1 suppresses ras-driven skin carcinogenesis through a nonapoptotic mechanism involving ARF and p53.

journal_name

Oncogene

journal_title

Oncogene

authors

Russell JL,Weaks RL,Berton TR,Johnson DG

doi

10.1038/sj.onc.1209120

subject

Has Abstract

pub_date

2006-02-09 00:00:00

pages

867-76

issue

6

eissn

0950-9232

issn

1476-5594

pii

1209120

journal_volume

25

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Mechanistic insight into taxol-induced cell death.

    abstract::We analysed the involvement of proteases during taxol-mediated cell death of human A549 non-small-cell lung carcinoma cells using a proteomics approach that specifically targets protein N termini and further detects newly formed N termini that are the result of protein processing. Our analysis revealed 27 protease-med...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.96

    authors: Impens F,Van Damme P,Demol H,Van Damme J,Vandekerckhove J,Gevaert K

    更新日期:2008-07-31 00:00:00

  • Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.

    abstract::Mxi1 is a basic region helix-loop-helix leucine zipper (bHLH/LZ) protein that, in association with Max, antagonizes Myc oncogenic activities. A possible mechanistic basis for Mxi1-mediated repression was provided by the recent demonstration that the repressive potential of Mxi1 correlates with its ability to physicall...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Rao G,Alland L,Guida P,Schreiber-Agus N,Chen K,Chin L,Rochelle JM,Seldin MF,Skoultchi AI,DePinho RA

    更新日期:1996-03-07 00:00:00

  • CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration.

    abstract::CD44 is a cell surface receptor for hyaluronate, a component of the extracellular matrix (ECM). Although CD44 has been implicated in tumor invasion and metastasis, the molecular mechanisms remain to be elucidated. Here we find that CD44 expressed in cancer cells is cleaved at the membrane-proximal region of the ectodo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202447

    authors: Okamoto I,Kawano Y,Tsuiki H,Sasaki J,Nakao M,Matsumoto M,Suga M,Ando M,Nakajima M,Saya H

    更新日期:1999-02-18 00:00:00

  • Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth.

    abstract::The E6 proteins originating from the tumour-associated Human Papillomavirus (HPV) types 16 and 18 have been shown to bind to and target the tumour suppressor protein, p53, for ubiquitin-mediated degradation. However, in cell lines derived from cervical neoplasias, the predominant early region transcripts are spliced a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201202

    authors: Pim D,Massimi P,Banks L

    更新日期:1997-07-17 00:00:00

  • Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target.

    abstract::Although activation of the STAT3 pathway has been associated with tumor progression in a wide variety of cancer types (including ovarian cancer), the precise mechanism of invasion and metastasis due to STAT3 are not fully delineated in ovarian cancer. We found that pSTAT3 Tyr705 is constitutively activated in patient ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.197

    authors: Saini U,Naidu S,ElNaggar AC,Bid HK,Wallbillich JJ,Bixel K,Bolyard C,Suarez AA,Kaur B,Kuppusamy P,Hays J,Goodfellow PJ,Cohn DE,Selvendiran K

    更新日期:2017-01-12 00:00:00

  • DNA: leukemia's secret weapon of bone mass destruction.

    abstract::Interaction of tumour cells with their microenvironment impacts on all aspects of cancer, ranging from development through to treatment response. In this issue, Dvorak and colleagues(1) reveal a novel tumour/microenvironment relationship that may drive leukemia pathogenesis. Specifically, they find that leukemic cells...

    journal_title:Oncogene

    pub_type: 评论,杂志文章

    doi:10.1038/onc.2012.639

    authors: Tait S

    更新日期:2013-10-31 00:00:00

  • Differential transcriptional regulation of the monocyte-chemoattractant protein-1 (MCP-1) gene in tumorigenic and non-tumorigenic HPV 18 positive cells: the role of the chromatin structure and AP-1 composition.

    abstract::The expression of the monocyte-chemoattractant-protein-1 (MCP-1) is closely linked with a non-tumorigenic phenotype in somatic cell hybrids made between the human papillomavirus type 18 (HPV 18) positive cervical carcinoma cell line HeLa and normal human fibroblasts. In contrast, MCP-1 transcription is absent in tumor...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203643

    authors: Finzer P,Soto U,Delius H,Patzelt A,Coy JF,Poustka A,zur Hausen H,Rösl F

    更新日期:2000-07-06 00:00:00

  • Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration.

    abstract::Proteinase-activated receptor 2 (PAR2) is a G protein-coupled receptor that is activated by trypsin-like proteinases. PAR2 is detected in breast tumor specimens; however, it is not clear how PAR2 level in breast cancer cell/tissues compares with normal cell/tissues. Here, we show the elevation of PAR2 protein level in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.163

    authors: Su S,Li Y,Luo Y,Sheng Y,Su Y,Padia RN,Pan ZK,Dong Z,Huang S

    更新日期:2009-08-27 00:00:00

  • Cloning and characterization of a novel gene encoding a putative transmembrane protein with altered expression in some human transformed and tumor-derived cell lines.

    abstract::Identification and characterization of genes expressed in normal cells and decreased in their malignant counterparts is an important method for detecting candidate tumor suppressors. Using differential display of mRNAs from nontumorigenic infinite life span human fibroblast cell strain MSU-1.1 and an isogenic fibrosar...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202290

    authors: Qing J,Wei D,Maher VM,McCormick JJ

    更新日期:1999-01-14 00:00:00

  • G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells.

    abstract::Inhibition of telomerase activity by telomerase inhibitors induces a gradual loss of telomeres, and this in turn causes cancer cells to enter to a crisis stage. Here, we report the telomerase inhibitor telomestatin, which is known to stabilize G-quadruplex structures at 3' single-stranded telomeric overhangs (G-tails)...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209217

    authors: Tahara H,Shin-Ya K,Seimiya H,Yamada H,Tsuruo T,Ide T

    更新日期:2006-03-23 00:00:00

  • c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis.

    abstract::c-Myc promotes cellular proliferation, sensitizes cells to apoptosis and prevents differentiation. It binds cyclin T1 structurally and functionally from the positive transcription elongation factor b (P-TEFb). The cyclin-dependent kinase 9 (Cdk9) in P-TEFb then phosporylates the C-terminal domain of RNA polymerase II,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206800

    authors: Kanazawa S,Soucek L,Evan G,Okamoto T,Peterlin BM

    更新日期:2003-08-28 00:00:00

  • The MYCN protein of human neuroblastoma cells is phosphorylated by casein kinase II in the central region and at serine 367.

    abstract::The MYCN gene has been implicated in certain neuronal tumours, such as neuroblastomas and retinoblastomas. These tumours express high levels of mRNA and protein of MYCN as a result of amplification. MYCN encodes a short-lived nuclear phosphoprotein whose function has not yet been elucidated. This study was undertaken ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Hamann U,Wenzel A,Frank R,Schwab M

    更新日期:1991-10-01 00:00:00

  • Expression of the naturally occurring truncated trkB neurotrophin receptor induces outgrowth of filopodia and processes in neuroblastoma cells.

    abstract::We have investigated the effects of the truncated trkB receptor isoform T1 (trkB.T1) by transient transfection into mouse N2a neuroblastoma cells. We observed that expression of trkB.T1 leads to a striking change in cell morphology characterized by outgrowth of filopodia and processes. A similar morphological response...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202401

    authors: Haapasalo A,Saarelainen T,Moshnyakov M,Arumäe U,Kiema TR,Saarma M,Wong G,Castrén E

    更新日期:1999-02-11 00:00:00

  • Hyperactive autocrine loop mediated by a NDF-related factor in neoplastic hamster embryo fibroblasts expressing an activated cph oncogene.

    abstract::We described previously the characterization of a novel oncogene, cph, activated in primary Syrian hamster embryo fibroblasts by exposure to 3-methylcholanthrene (Velasco et al., Oncogene 9:2065-2069, 1994). The present report describes the participation in the neoplastic conversion of cph-expressing (81C39) hamster f...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Avila MA,Velasco JA,Cho C,Lupu R,Wen D,Notario V

    更新日期:1995-03-02 00:00:00

  • Type I collagen is a molecular target for inhibition of angiogenesis by endogenous thrombospondin-1.

    abstract::Three-dimensional explant cultures of muscle tissue were used to characterize secreted proteins regulated by endogenous levels of the angiogenesis modulator thrombospondin (TSP)-1. Explants from TSP1 null mice exhibit enhanced neovascularization associated with increased endothelial outgrowth but decreased outgrowth o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209069

    authors: Zhou L,Isenberg JS,Cao Z,Roberts DD

    更新日期:2006-01-26 00:00:00

  • GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuring.

    abstract::GRIM-19 (Gene associated with Retinoid-Interferon-induced Mortality 19) is a novel tumor suppressor regulated by interferon/retinoid combination. We have recently shown that GRIM-19 inhibits v-Src-induced oncogenic transformation and metastatic behavior of cells. Oncogenic v-Src induces cell motility by cytoskeletal r...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.480

    authors: Sun P,Nallar SC,Kalakonda S,Lindner DJ,Martin SS,Kalvakolanu DV

    更新日期:2009-03-12 00:00:00

  • Evidence for human DNA-mediated transfer of the suppressed phenotype into malignant Chinese hamster cells.

    abstract::Genetic suppression of the neoplastic phenotype has been demonstrated in somatic cell hybrids between tumor and normal cells. Suppression in whole-cell and microcell hybrids cannot, as yet, be attributed to specific elements defined at the molecular level. To identify a gene capable of suppressing the neoplastic pheno...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Schäfer R,Nirkko AC,Ambühl PM,Grzeschik KH,Schwarte-Waldhoff I

    更新日期:1991-12-01 00:00:00

  • Fas signaling promotes motility and metastasis through epithelial-mesenchymal transition in gastrointestinal cancer.

    abstract::Fas signaling was reported to participate in cell apoptosis. However, this pathway has also been shown to promote tumor cell motility, leading to the hypothesis that Fas signaling may induce epithelial-mesenchymal transition (EMT) to promote metastasis. The effects of Fas-ligand (FasL) treatment and inhibition of Fas ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.126

    authors: Zheng HX,Cai YD,Wang YD,Cui XB,Xie TT,Li WJ,Peng L,Zhang Y,Wang ZQ,Wang J,Jiang B

    更新日期:2013-02-28 00:00:00

  • Triggering of p73-dependent apoptosis in osteosarcoma is under the control of E2Fs-pRb2/p130 complexes.

    abstract::Mechanisms underlying multidrug resistance (MDR), one of the major causes of cancer treatment failure, are still poorly understood. We selected the osteosarcoma MDR HosDXR150 cell line by culturing Hos cells in the presence of increasing doxorubicin doses and showed that it is crossresistant to vinblastine. Similarly ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206487

    authors: La Sala D,Macaluso M,Trimarchi C,Giordano A,Cinti C

    更新日期:2003-06-05 00:00:00

  • Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma.

    abstract::Multiple endocrine neoplasia type 2 (MEN 2) is an inherited cancer syndrome that includes pheochromocytoma. Germline mutations in RET are responsible for MEN 2 but the precise pathogenetic mechanisms of tumorigenesis are unknown. We have recently identified possible mechanisms of tumor formation in patients with MEN 2...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205133

    authors: Koch CA,Huang SC,Zhuang Z,Stolle C,Azumi N,Chrousos GP,Vortmeyer AO,Pacak K

    更新日期:2002-01-17 00:00:00

  • Targeting Id protein interactions by an engineered HLH domain induces human neuroblastoma cell differentiation.

    abstract::Inhibitor of DNA-binding (Id) proteins prevent cell differentiation, promote growth and sustain tumour development. They do so by binding to E proteins and other transcription factors through the helix-loop-helix (HLH) domain, and inhibiting transcription. This makes HLH-mediated Id protein interactions an appealing t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.56

    authors: Ciarapica R,Annibali D,Raimondi L,Savino M,Nasi S,Rota R

    更新日期:2009-04-30 00:00:00

  • The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding.

    abstract::The BTB/POZ family of proteins has been implicated in multiple biological processes, including tumourigenesis, DNA damage responses and cell cycle progression and development. MIZ-1 (Myc-interacting zinc-finger protein 1) is known to activate transcription of CDKN1A. We recently found that a kidney cancer-related POK ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.331

    authors: Lee KM,Choi WI,Koh DI,Kim YJ,Jeon BN,Yoon JH,Lee CE,Kim SH,Oh J,Hur MW

    更新日期:2012-03-15 00:00:00

  • The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A.

    abstract::A yeast two-hybrid screen has identified HBP1 as a transcription factor capable of interacting with the pocket protein family. We show that HBP1 can interact with one of these, RB, both in vitro and in mammalian cells. Two distinct RB binding sites are present within HBP1--a high affinity binding site, mediated by an ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201243

    authors: Lavender P,Vandel L,Bannister AJ,Kouzarides T

    更新日期:1997-06-05 00:00:00

  • Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis.

    abstract::We have recently described the N-terminal RAS association domain family of genes, RASSF7-10. Previously, we cloned the N-terminal RASSF10 gene and demonstrated frequent methylation of the associated 5'-CpG island in acute lymphoblastic leukemia. To characterize RASSF10 gene expression, we demonstrate that in developin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.471

    authors: Hill VK,Underhill-Day N,Krex D,Robel K,Sangan CB,Summersgill HR,Morris M,Gentle D,Chalmers AD,Maher ER,Latif F

    更新日期:2011-02-24 00:00:00

  • TAS4464, a NEDD8-activating enzyme inhibitor, activates both intrinsic and extrinsic apoptotic pathways via c-Myc-mediated regulation in acute myeloid leukemia.

    abstract::TAS4464, a potent, selective small molecule NEDD8-activating enzyme (NAE) inhibitor, leads to inactivation of cullin-RING E3 ubiquitin ligases (CRLs) and consequent accumulations of its substrate proteins. Here, we investigated the antitumor properties and action mechanism of TAS4464 in acute myeloid leukemia (AML). T...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01586-4

    authors: Ochiiwa H,Ailiken G,Yokoyama M,Yamagata K,Nagano H,Yoshimura C,Muraoka H,Ishida K,Haruma T,Nakayama A,Hashimoto N,Murata K,Nishimura M,Kawashima Y,Ohara O,Ohkubo S,Tanaka T

    更新日期:2021-01-08 00:00:00

  • Sequence and biological activity of chicken snoN cDNA clones.

    abstract::cDNA clones of the ski-related gene, sno, were isolated from a chicken cDNA library and sequenced. In contrast to the human system, from which two forms of sno cDNAs have been isolated, we obtained only one type of chicken sno cDNA, that encoding snoN. The coding region for chicken snoN was inserted into the retrovira...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Boyer PL,Colmenares C,Stavnezer E,Hughes SH

    更新日期:1993-02-01 00:00:00

  • A novel assay for the measurement of Raf-1 kinase activity.

    abstract::Raf-1 is a serine-threonine protein kinase that functions as a central component of the mitogen-activated protein kinase signal transduction pathway. Raf-1 activity is currently assayed in vitro by either measuring 32P incorporation into MEK, Raf-1's only characterized substrate, or by using the phosphorylated MEK to ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203862

    authors: Bondzi C,Grant S,Krystal GW

    更新日期:2000-10-12 00:00:00

  • neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.

    abstract::We have previously shown that each of four activated oncogenes (c-myc, neu, ras, and int-2) can serve as transgenic initiators of morphologically distinct adenocarcinomas of the murine mammary gland. Since abnormalities of these oncogenes are found frequently in human breast cancers, such differences are of particular...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Morrison BW,Leder P

    更新日期:1994-12-01 00:00:00

  • R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation.

    abstract::Within the superfamily of ras-related GTP-binding proteins, only ras itself has been shown to act as an oncogene. Seven other proteins, however, have greater than 50% amino acid identity to ras and one of them, rap1A, has been shown to interact with the ras GTPase activating protein, ras-GAP, and to inhibit ras functi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Rey I,Taylor-Harris P,van Erp H,Hall A

    更新日期:1994-03-01 00:00:00

  • DroVav, the Drosophila melanogaster homologue of the mammalian Vav proteins, serves as a signal transducer protein in the Rac and DER pathways.

    abstract::Mammalian Vav signal transducer proteins couple receptor tyrosine kinase signals to the activation of the Rho/Rac GTPases, leading to cell differentiation and/or proliferation. The unique and complex structure of mammalian Vav proteins is preserved in the Drosophila melanogaster homologue, DroVav. We demonstrate that ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207027

    authors: Hornstein I,Mortin MA,Katzav S

    更新日期:2003-10-02 00:00:00